Table of Contents
What does View Ray do?
The ViewRay system gathers data from all points in the radiation therapy process—the physician-prescribed treatment plan, pretreatment images, and soft-tissue images and motion data captured during therapy—and gives clinicians the means to apply that wealth of data.
How many MRI-LINAC’s are there?
Since its publication, the MRI-Linac has gained 510(k) and CE approval and there are now around 30 systems in clinical use around the globe.
Who makes the MRI-LINAC?
In 2012, MR-linac manufacturer Elekta and its technology partner Philips formed the MR-linac Consortium — an international research collaboration set up to study image-guided radiotherapy and help facilitate evidence-based introduction of the technology.
When did ViewRay go public?
Aug. 14, 2018
CLEVELAND , Aug. 14, 2018 /PRNewswire/ — ViewRay, Inc.
Is MRI radiation therapy?
MRI-guided radiation therapy uses magnetic resonance imaging (MRI) together with radiotherapy to treat tumors and cancers throughout the body. The use of MRI during radiotherapy enables the most precise targeting of radiation by accurately tracking the position and shape of a patient’s tumor.
How many linacs are there in the United States?
Results: There are 428 dedicated SRS systems in the United States, with linac-based systems the most common (39%), followed by CK (35%) and GK (26%).
Is Viewray a public company?
BTIG Thinks Viewray’s Stock is Going to Recover The company’s shares closed last Wednesday at $3.83, close to its 52-week low of $3.43.
Is VRAY a buy?
ViewRay (VRAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects.
Will VRAY stock go up?
Stock Price Forecast The 6 analysts offering 12-month price forecasts for ViewRay Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +180.90% increase from the last price of 2.67.
What is ViewRay®?
A new kind of medical technology company—ViewRay® Inc. designs, manufactures and markets MRIdian, the world’s first MRI-Guided radiation therapy system to image and treat cancer patients simultaneously.
Why choose ViewRay technologies for radiation therapy?
ViewRay has a new vision for radiation therapy, and you can be part of it. © 2021 ViewRay Technologies, Inc. (“ViewRay”). All rights reserved. Intended for healthcare professionals only.
Who is the chairman of ViewRay?
And ViewRay holds the exclusive worldwide license for its combination of MRI and radiation therapy technologies. Daniel Moore has served as a member of our board of directors and our Chair since February 2018. Mr. Moore has served as Chairman of the Board for medical device company LivaNova, PLC (NASDAQ: LIVN) since September 2015.
Who is Scott Drake and what is ViewRay?
Scott Drake is a proven leader in the medical device space. He is currently the President and CEO of ViewRay, an MRI-guided radiation therapy company with leading technology.